Immediate Impact
58 standout
Citing Papers
Neutrophil extracellular traps in homeostasis and disease
2024 Standout
Antimicrobial Peptides towards Clinical Application—A Long History to Be Concluded
2024 Standout
Works of Christopher Geven being referenced
A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2)
2019
Experimental human endotoxemia as a model of systemic inflammation
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Christopher Geven | 178 | 171 | 112 | 153 | 11 | 494 | |
| Takashi Nagura | 169 | 144 | 142 | 151 | 12 | 543 | |
| Hans‐Dirk Düngen | 38 | 64 | 101 | 292 | 22 | 526 | |
| Tanenao Eto | 314 | 56 | 285 | 141 | 12 | 540 | |
| Irshad H. Chaudry | 45 | 111 | 67 | 22 | 12 | 417 | |
| P. W. Eichenholz | 22 | 190 | 125 | 142 | 6 | 529 | |
| R. Savanh Chanthaphavong | 46 | 83 | 115 | 42 | 15 | 552 | |
| D. Bell | 39 | 53 | 69 | 102 | 21 | 424 | |
| Michael Peters | 35 | 135 | 82 | 153 | 14 | 574 | |
| Ilona Cuijpers | 35 | 126 | 144 | 285 | 11 | 531 | |
| R. Witthaut | 19 | 182 | 84 | 268 | 17 | 559 |
All Works
Login with ORCID to disown or claim papers
Loading papers...